Helping You Build Wealth With Honest Research
Since 1996. Read On...

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

EVEREST ORGANICS Plunges 5%; BSE HEALTHCARE Index Down 1.2%
Mon, 4 Nov 10:42

EVEREST ORGANICS Plunges 5%; BSE HEALTHCARE Index Down 1.2%Image source: KanawatTH/www.istockphoto.com

EVEREST ORGANICS share price has plunged 5% and is presently trading at Rs 121.1.

Meanwhile, the BSE HEALTHCARE index is at 43,672.0 (down 1.2%).

Among the top losers in the BSE HEALTHCARE index today are Jubilant Pharmova (down 5.3%) and Sun Pharma (down 3.9%).

KIMS (up 2.9%) and MAX HEALTHCARE INSTITUTE (up 1.4%) are among the top gainers today.

Over the last one year, EVEREST ORGANICS has moved up from Rs 117.3 to Rs 121.1, registering a gain of Rs 3.8 (up 3.2%).

On the other hand, the BSE HEALTHCARE index has moved up from 27,271.8 to 43,672.0, registering a gain of 60.1% during the last 12 months.

The top gainers among the BSE HEALTHCARE index stocks during this same period were Jubilant Pharmova (up 221.6%), SUVEN PHARMACEUTICALS (up 128.4%) and Glenmark Pharma (up 122.9%).

Dear Reader: If You Invest in Midcap Stocks, this is for You

What About the Benchmark Indices?

The BSE Sensex is at 78,591.5 (down 1.6%).

The top losers among the BSE Sensex today are Sun Pharma (down 3.9%) and NTPC (down 3.7%). The most traded stocks in the BSE Sensex are ICICI Bank and Reliance Ind..

In the meantime, NSE Nifty is at 23,919.1 (down 1.6%). IOC and Hero Motocorp are among the top losers in NSE NIFTY.

Over the last 12 months, the BSE Sensex has moved up from 63,874.9 to 78,591.5, registering a gain of 14,716.6 points (up 23.0%).

EVEREST ORGANICS Financial Update...

EVEREST ORGANICS net profit fell 18008.8% YoY to Rs -61 million for the quarter ended June 2024, compared to a profit of Rs 0 million a year ago. Net sales declined 24.0% to Rs 324 million during the period as against Rs 427 million in April-June 2023.

For the year ended March 2023, EVEREST ORGANICS reported 115.9% decrease in net profit to Rs -2 million compared to net profit of Rs 11 million during FY22. Revenue of the company fell 7.4% to Rs 1,574 million during FY23.

The current Price to earnings ratio of EVEREST ORGANICS, based on rolling 12 month earnings, stands at -16.2.


Equitymaster requests your view! Post a comment on "EVEREST ORGANICS Plunges 5%; BSE HEALTHCARE Index Down 1.2%". Click here!